Medicinal Chemistry Research

Medicinal Chemistry Research

药物化学研究

  • 4区 中科院分区
  • Q3 JCR分区

期刊简介

《Medicinal Chemistry Research》是由Springer US出版社于2004年创办的英文国际期刊(ISSN: 1054-2523,E-ISSN: 1554-8120),该期刊长期致力于药物化学领域的创新研究,主要研究方向为医学-医药化学。作为SCIE收录期刊(JCR分区 Q3,中科院 4区),本刊采用OA未开放获取模式(OA占比0.0461...%),以发表药物化学领域等方向的原创性研究为核心(研究类文章占比71.86%%)。凭借严格的同行评审与高效编辑流程,期刊年载文量精选控制在167篇,确保学术质量与前沿性。成果覆盖Web of Science、Scopus等国际权威数据库,为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Medicinal Chemistry Research审稿周期约为 约5.0个月 。该刊近年未被列入国际预警名单,年发文量约167篇,录用竞争适中,主题需确保紧密契合医学前沿。投稿策略提示:避开学术会议旺季投稿以缩短周期,语言建议专业润色提升可读性。

  • 医学 大类学科
  • English 出版语言
  • 是否预警
  • SCIE 期刊收录
  • 167 发文量

中科院分区

中科院 SCI 期刊分区 2023年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
4区
CHEMISTRY, MEDICINAL 药物化学
4区

中科院 SCI 期刊分区 2022年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
4区
CHEMISTRY, MEDICINAL 药物化学
4区

JCR分区

按JIF指标学科分区 收录子集 分区 排名 百分位
学科:CHEMISTRY, MEDICINAL SCIE Q3 44 / 72

39.6%

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:CHEMISTRY, MEDICINAL SCIE Q3 45 / 72

38.19%

CiteScore

CiteScore SJR SNIP CiteScore 排名
CiteScore:4.7 SJR:0.41 SNIP:0.695
学科类别 分区 排名 百分位
大类:Pharmacology, Toxicology and Pharmaceutics 小类:General Pharmacology, Toxicology and Pharmaceutics Q1 15 / 80

81%

大类:Pharmacology, Toxicology and Pharmaceutics 小类:Organic Chemistry Q2 95 / 211

55%

期刊发文

  • Medicinal chemistry insights into non-hydroxamate HDAC6 selective inhibitors

    Author: Faridoon; Zha, Yuqi Lavender; Zhang, Guiping; Li, Jie Jack

    Journal: MEDICINAL CHEMISTRY RESEARCH. 2023; Vol. 32, Issue 1, pp. 1-14. DOI: 10.1007/s00044-022-02987-8

  • Optimization of clofibrate with natural product sesamol for reducing liver injury induced by acetaminophen

    Author: Han, Chuchu; Zhang, Linyang; Hua, Yuxin; Liu, Haitao; Liu, Jiping; Shi, Yongheng; Wang, Xiaoping; Wang, Wei; Jiang, Yi; Zhang, Huawei; Deng, Chong; Xie, Yundong; He, Shipeng; Liu, Ying

    Journal: MEDICINAL CHEMISTRY RESEARCH. 2023; Vol. 32, Issue 1, pp. 38-46. DOI: 10.1007/s00044-022-02989-6

  • Synthesis of myricetin derivatives and evaluation of their hypoglycemic activities

    Author: Li, Feng; Yang, Chong; Zhang, Liang; Li, Wenbao

    Journal: MEDICINAL CHEMISTRY RESEARCH. 2023; Vol. 32, Issue 1, pp. 76-84. DOI: 10.1007/s00044-022-02992-x

  • Design, synthesis and anticancer activity studies of novel indole derivatives as Bcl-2/Mcl-1 dual inhibitors

    Author: Liu, Yingfei; Li, Jianjun; Zhou, Guanghui; Zhang, Jiale; Teng, Yu; Bai, Zhushuang; Liu, Tingting

    Journal: MEDICINAL CHEMISTRY RESEARCH. 2023; Vol. 32, Issue 1, pp. 99-108. DOI: 10.1007/s00044-022-02991-y

  • Design, synthesis and biological evaluation of aminopyrimidine derivatives bearing dihydroquinoxalinone as novel EGFR(L858R/T790M) kinase inhibitors against non-small-cell lung cancer

    Author: Fu, Liping; Cao, Yu; Chen, Jingbai; He, Ruoyu; Zhao, Yanmei; Zhao, Yaping; Xi, Jianjun; Zhuang, Rangxiao; Tian, Chongmei

    Journal: MEDICINAL CHEMISTRY RESEARCH. 2023; Vol. , Issue , pp. -. DOI: 10.1007/s00044-023-03054-6

  • Design, synthesis and evaluation of salicylic acid-donepezil hybrids as functional agents for the treatment of Alzheimer's disease

    Author: He, Ying; Rao, Zhili; Liu, Zhengwei; Mi, Jing; Yang, Jing; Zhou, Yi; Yin, Zhigang; Chen, Peiyu; Liu, Wenmin; Zeng, Nan; Sang, Zhipei

    Journal: MEDICINAL CHEMISTRY RESEARCH. 2023; Vol. , Issue , pp. -. DOI: 10.1007/s00044-022-03010-w

  • Rational design and development of novel NAE inhibitors for the treatment of pancreatic cancer

    Author: Lu, Cheng; Lu, Peng; Gong, Lei; Zhu, Li-Juan; An, Yuanyuan; Wang, Yubin

    Journal: MEDICINAL CHEMISTRY RESEARCH. 2023; Vol. 32, Issue 3, pp. 442-474. DOI: 10.1007/s00044-022-02979-8

  • Design, synthesis and anti-TB and anti-bacterial activity of Ciprofloxacin derivatives containing N-(amino)piperazine moieties

    Author: Qin, Xiaoyu; Jiang, Bin; Song, Huijuan; Du, Na; Zhang, Yuehao; Zhong, Xijun; Wu, Jizhou; Xue, Tiezheng; Liu, Mingliang; Wang, Apeng; Wang, Sanlong; Lv, Kai

    Journal: MEDICINAL CHEMISTRY RESEARCH. 2023; Vol. 32, Issue 3, pp. 556-570. DOI: 10.1007/s00044-023-03023-z